No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
All the way up! The Innovative Drugs Sector in Hong Kong stocks surged collectively, with multiple stocks doubling this year. Who is reshaping the valuation?
The rise in the Hong Kong stock market's Innovative Drugs Sector continues. Market analysts point out that this wave of Innovative Drugs momentum benefits from a combination of factors including market sentiment, policy, and the realization of the companies' own commercial value.
The Hong Kong stock market for Medical stocks is surging! In February, the strongest has risen over 220%, what happened?
Recently, the General Office of the State Council forwarded the "2025 Action Plan for Stabilizing Foreign Investment" from the Ministry of Commerce and the National Development and Reform Commission, promoting the orderly opening of the Biomedical sector.
Announcement Highlights | Alibaba officially announces a 380 billion yuan investment plan for AI; Sutech Innovate expects annual revenue to significantly increase by approximately 45.5% to 49.1% year-on-year.
CLP HOLDINGS is expected to have a revenue of approximately 90.964 billion HKD in 2024, a year-on-year increase of 4.35%, with a Net income of 11.742 billion HKD, reflecting a year-on-year growth of 76.44%.
《Performance》CT ENTERPRISE (03839.HK) reported a net profit of 11.17 million USD for the year, an increase of 3.4 times, with no dividend declared.
CT ENTERPRISE (03839.HK) announced its annual results for the year ending in 2024, reporting revenue of 0.308 billion USD, an increase of 76.9% year-on-year. It recorded a net profit of 11.17 million USD, growing by 337.4%, with earnings per share at 4.41 cents. No final dividend will be distributed.
CT ENTERPRISE: Announcement of Annual Results for the Year Ended 31 December 2024, Proposed Adoption of New Share Option Scheme and Termination of Existing Share Option Scheme
CT ENTERPRISE (03839.HK) plans to hold a Board of Directors meeting on February 24 to approve its annual performance.
On February 10, Gelonghui reported that CT ENTERPRISE (03839.HK) announced that the Board of Directors will hold a meeting on February 24, 2025 (Monday) to approve the annual performance of the company and its subsidiaries for the year ended December 31, 2024, and to consider the distribution of a final dividend (if any).
